Replies to post #24226 on Anavex Life Sciences Corp (AVXL)

[JB3729]

Yes stealthways, I thought that science related post was excellent. The pre-clinical results are more meaningful to me as well. Here's more of the epileptologist's posts -

http://finance.yahoo.com/mbview/userview/;_ylt=AhPSdISmu324bDbkfelkpLTeAohG;_ylu=X3oDMTB1cHB2cjA0BHBvcwMyBHNlYwNNZWRpYU1zZ0JvYXJkc1hIUlVsdA--;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&u=dadofmarcmax&bn=04bae8c0-3391-3115-ad23-19e486e82827&page=1

[frrol]

Murine (mouse) Alzheimer models are not very reliable:
https://www.yahoo.com/news/scientists-identify-protein-key-alzheimers-treatment-204609143.html
The joke in biotech is that mouse cancer and dementia has been cured. Many times.
It's nice to have strong pre-clinicals, but EVERY failed clinical trial was preceded by successful pre-clinicals.
We have to wait for human clinical trial results. Fingers crossed.

[JB3729]

From 2013, more on pre-clinical and Anavex Life Sciences Corp. (AVXL.OB) Comments on FDA Plan to Expedite Approval of New Alzheimer's Drugs

As reported by the New York Times, drugs in clinical trials would qualify for approval if people with very early-stage Alzheimer's showed even subtle improvement in memory or reasoning tests. ANAVEX 2-73, the company's lead compound for Alzheimer's disease, has successfully completed a Phase 1 clinical trial in humans.

http://www.biospace.com/News/anavex-life-sciences-corp-comments-on-fda-plan-to/290821